Draw/line
Education and research purposes only, not medical advice. Unapproved compounds are not for human consumption. Check every result with your prescriber. Disclaimer Research and education only. Not medical advice. Disclaimer
Home / Compounds / Hexarelin

Hexarelin

Hexarelin (examorelin): a growth hormone releasing peptide never approved anywhere, its human studies, hormone side effects and sport ban.

Investigational, not approved · Evidence grade C · Reviewed

Not approved by the FDA for human use. Not for human consumption. This page describes Hexarelin only to explain its regulatory status, what has been studied and its known risks. Drawline does not recommend obtaining or using it. Disclaimer

Approved and studied uses
  • Not approvedGrowth hormoneStudied in the 1990s; never approved
Training and drug testingBanned at all times

WADA bans it by name at all times under class S2, as a growth hormone releasing peptide.

Drug-tested athletes can look up any substance on Global DRO, run by national anti-doping agencies. Supplements can contain banned substances that are not on the label. Drawline does not suggest when to train or inject.

Hexarelin (Examorelin). Growth hormone secretagogue.

CInvestigational, not approved. Evidence grade C: limited, early or dated human data.

What is Hexarelin?

Hexarelin is a synthetic six-amino-acid peptide in the growth hormone releasing peptide (GHRP) family. It makes the pituitary release growth hormone and also binds a heart receptor called CD36.

Is Hexarelin FDA-approved?

Hexarelin was studied as a drug in the 1990s but was never approved by FDA or, as far as we found, any other regulator. No hexarelin product can be legally sold in the United States as a medicine. Products sold online as research chemicals are unapproved.

What does the evidence show for Hexarelin?

Small human pharmacology studies from the 1990s, mostly in Italy, show it raises growth hormone in a dose-related way. There are no large trials showing a health benefit, and its heart effects come mainly from animal studies.

What are the known risks of Hexarelin?

In human studies it also raised prolactin, ACTH and cortisol, so it is not specific to growth hormone. Long-term safety in people is unknown, and research-chemical products have no assurance of identity, purity or sterility. Sport: WADA bans it by name at all times under class S2, as a growth hormone releasing peptide.

How is Hexarelin measured?

A powder vial: enter the amount in the vial and the water added, and the calculator shows the syringe units for a prescribed dose. Products sold online as "research use only" have no assurance of identity, dose or sterility. The calculator can do the arithmetic for any vial, but it cannot tell you what is actually in one.

Sources: Hexarelin-induced GH, cortisol and prolactin release: dose-response study (1996); CD36 mediates the cardiovascular action of growth hormone releasing peptides (2002); The cardiovascular action of hexarelin, review (2014); WADA: 2026 Prohibited List. This profile does not recommend any dose or use.

For research and educational use. Not medical advice. Regulatory status changes, so confirm the current position with FDA or a licensed professional.

Spot a mistake or an out-of-date fact? Report an error. We check every report against the sources.